|
|
|
|
Search published articles |
|
|
Showing 2 results for Aspergillus Flavus
Kazemi A, Nowrozi H, Teshfam M, Teimorian Sh, Volume 15, Issue 4 (12-2013)
Abstract
Background and Objective: Aspergillosis is the most current causative agent of exogenous fungal nosocomial infection. This study was done to evaluate the drug susceptibility of Aspergillus flavus and A.fumigatus to itraconazole and amphotericin B. Materials and Methods: This Laboratory study was done on 25 Aspergillus fumigatus and 25 Aspergillus flavus species isolated from transplant's patients. Drug susceptibility test was done according to NCCLS M38-P document. Fungal suspensions of mentioned fungi were supplied with ranges 0.5–5×104 by spectrophotometer at 530 nm. Serial dilutions of drugs were supplied from 0.03125 to 16 µg/ml and MICs determined following 48h incubation at 35°C. Results: Obtained MICs ranges for Aspergillus fumigatus and Aspergillus flavus were 1-4 µg/ml and 0.5–4 µg/ml for itraconazole, respectively while MICs ranges against Aspergillus fumigatus and Aspergillus flavus were 0.5-2 µg/ml and 0.25-2 µg/ml for amphotericin B, respectively. Amphotericin B MICs were significantly lower than itraconazole (P<0.05). Conclusion: Aspergillus flavus and A.fumigatus were susceptible to amphotericin B and itraconazole.
Mohammad Abbaszadeh , Vahid Tanhaie Marand , Hassan Malekinejad , Volume 26, Issue 1 (3-2024)
Abstract
Background and Objective: Bacterial nanocellulose is known as a potential carrier for a widespread spectrum of biological compounds, including antibacterial and antifungal compounds. The present study was conducted to determine the impact of bacterial nanocellulose containing Natamycin and Amphotericin B on Aspergillus flavus and Penicillium citrinum in an in vitro environment.
Methods: In this descriptive-analytical research, Aspergillus flavus-PTCC: 5006 and Penicillium citrinum-PTCC: 5304 fungi were prepared from the Fungal Collection of the Department of Microbiology, Faculty of Veterinary Medicine, Urmia University. The minimum inhibitory concentration (MIC) and the minimum fungicidal concentration (MFC) of Natamycin and Amphotericin B against Aspergillus flavus and Penicillium citrinum were evaluated by the microdilution method. Bacterial nanocellulose was prepared using Komagata xylinum bacterium, and Natamycin and Amphotericin B were added in three concentrations of 0.01%, 0.05%, and 0.1% to wet and lyophilized nanocellulose films by the immersion method. Then, the antifungal effects of the film containing the above compounds against the investigated fungi were investigated by the agar diffusion method. Parchment paper was used as a control for comparison. Spectral properties of nanocellulose film containing antifungal compounds were evaluated by the Fourier transform infrared (FTIR) method.
Results: MIC and MFC of Natamycin for Aspergillus flavus were determined as 3.9 μg/mL and 7.81 μg/mL, and for Penicillium citrinum as 7.81 μg/mL and 15.62 μg/mL, respectively. MIC and MFC of Amphotericin B for Aspergillus flavus were determined as 7.81 μg/mL and 15.62 μg/mL, and for Penicillium citrinum as 15.62 μg/mL and 31.25 μg/mL, respectively. The increased concentration had a statistically significant impact on the antifungal properties of all films (P<0.05). The best antifungal effects of the film were related to the film containing Natamycin.
Conclusion: Bacterial nanocellulose containing Natamycin showed stronger antifungal effects in an in vitro environment compared to Amphotericin B against Aspergillus flavus and Penicillium citrinum.
|
|
|
|
|
|